Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
STEM > SEC Filings for STEM > Form 8-K on 5-Aug-2013All Recent SEC Filings

Show all filings for STEMCELLS INC



Other Events, Financial Statements and Exhibits

Item 8.01 Other Events.

On August 2, 2013, StemCells, Inc. (the "Company") issued a press release announcing positive two-year clinical results from the study of its proprietary HuCNS-SC cells in patients with Pelizaeus-Merzbacher disease. Notably, the neurological and MRI changes seen in the patients since transplantation of the cells suggest a departure from the natural history of the disease and may represent signals of a clinical effect. A copy of this press release is attached hereto as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit 99.1 Press Release, dated August 2, 2013, announcing two-year data from the Company's clinical study of HuCNS-SC cells in patients with Pelizaeus-Merzbacher disease.

Top of the Form

  Add STEM to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for STEM - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.